IMMUNOHISTOCHEMICAL ANALYSIS OF P53 AND HER-2/NEU PROTEINS IN HUMAN TUMORS

被引：82

作者：

CHANG, K ^{[1
]}

DING, I ^{[1
]}

KERN, FG ^{[1
]}

WILLINGHAM, MC ^{[1
]}

机构：

[1] GEORGETOWN UNIV,MED CTR,VINCENT T LOMBARDI CANC RES CTR,WASHINGTON,DC 20007

来源：

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY | 1991年 / 39卷 / 09期

关键词：

P53; HER-2/NEU; IMMUNOHISTOCHEMISTRY; PEROXIDASE; HUMAN BREAST CANCER; COLON CANCER; OVARIAN CANCER;

D O I：

10.1177/39.9.1680897

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

We examined samples of tumors of human breast, ovary, and colon of various degrees of malignancy for the expression of p53 protein, using a panel of anti-p53 antibodies and peroxidase immunohistochemistry. Of 66 tumor cases (24 cases of ovarian carcinoma, 23 cases of colon adenocarcinoma, and 19 cases of breast carcinoma), 36 (53%) showed high levels of expression of p53 using a human-specific antibody, and 16 (24%) showed high expression of a mutant form of p53. In the mutant p53-positive breast tumor samples, six (86%) were positive for HER-2/neu reactivity, compared with colon (0/4) and ovarian tumors (115). The pattern of p53 intracellular localization and tissue distribution, and the relationship between the expression of mutant p53 and cell differentiation, were also examined; poorly differentiated cells showed either overexpression of p53 of higher levels of mutant p53 in comparison with more normal cells.

引用

页码：1281 / 1287

页数：7

共 30 条

[21]

MACKAY J, 1988, LANCET, V2, P1384

[22]

MERCER WE, 1990, ONCOGENE, V5, P979

[23] MECHANISMS OF P53 LOSS IN HUMAN SARCOMAS [J].

MULLIGAN, LM ;

MATLASHEWSKI, GJ ;

SCRABLE, HJ ;

CAVENEE, WK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5863-5867

[24] MUTATIONS IN THE P53 GENE OCCUR IN DIVERSE HUMAN-TUMOR TYPES [J].

NIGRO, JM ;

BAKER, SJ ;

PREISINGER, AC ;

JESSUP, JM ;

HOSTETTER, R ;

CLEARY, K ;

BIGNER, SH ;

DAVIDSON, N ;

BAYLIN, S ;

DEVILEE, P ;

GLOVER, T ;

COLLINS, FS ;

WESTON, A ;

MODALI, R ;

HARRIS, CC ;

VOGELSTEIN, B .

NATURE, 1989, 342 (6250) :705-708

[25]

PROSSER J, 1990, ONCOGENE, V5, P1573

[26]

STRATTON MR, 1990, ONCOGENE, V5, P1297

[27] P53 - A FREQUENT TARGET FOR GENETIC ABNORMALITIES IN LUNG-CANCER [J].

TAKAHASHI, T ;

NAU, MM ;

CHIBA, I ;

BIRRER, MJ ;

ROSENBERG, RK ;

VINOCOUR, M ;

LEVITT, M ;

PASS, H ;

GAZDAR, AF ;

MINNA, JD .

SCIENCE, 1989, 246 (4929) :491-494

[28] IDENTIFICATION OF INTRONIC POINT MUTATIONS AS AN ALTERNATIVE MECHANISM FOR P53 INACTIVATION IN LUNG-CANCER [J].

TAKAHASHI, T ;

DAMICO, D ;

CHIBA, I ;

BUCHHAGEN, DL ;

MINNA, JD .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :363-369

[29] P53 GENE MESSENGER-RNA EXPRESSION AND CHROMOSOME 17P ALLELE LOSS IN BREAST-CANCER [J].

THOMPSON, AM ;

STEEL, CM ;

CHETTY, U ;

HAWKINS, RA ;

MILLER, WR ;

CARTER, DC ;

FORREST, APM ;

EVANS, HJ .

BRITISH JOURNAL OF CANCER, 1990, 61 (01) :74-78

[30] EXPRESSION OF THE NUCLEAR ONCOGENE P53 IN COLON TUMORS [J].

VANDENBERG, FM ;

TIGGES, AJ ;

SCHIPPER, MEI ;

DENHARTOGJAGER, FCA ;

KROES, WGM ;

WALBOOMERS, JMM .

JOURNAL OF PATHOLOGY, 1989, 157 (03) :193-199

← 1 2 3 →